2 FEBRUARY 2006

NEW ZEALAND GAZETTE, No. 10

Diphenylpyraline; except when specified elsewhere in the Schedule
Doxylamine; except when specified elsewhere in the Schedule
Drotrecogin
Duboisia leichhardtii; except when specified elsewhere in the Schedule
Duboisia myoporides; except when specified elsewhere in the Schedule
Duloxetine
Efalizumab
Emtricitabine
Enfuvirtide
Entecavir
Eplerenone
Epinastine
Ephedra spp; except ephedra navadensis
Epoetins
Erlotinib
Ethyl chloride; for inhalation
Etidocaine
Everolimus
Ezetimibe
Felypressin; except when combined with a local anaesthetic and when used in practice by a registered dental therapist
Fenofibrate
Flunisolide
Fluorides; except when specified elsewhere in the Schedule; except in parenteral nutrition replacement preparations; for external use in medicines other than pastes, gels or powders for cleaning the teeth containing more than 2.5% except when used in practice by a registered dental therapist; except in medicines containing 1.5 milligrams or less per litre or per kilogram
Folic acid; for injection
Folinic acid; for injection
Fosamprenavir
Fulvestrant
Gefitinib
Glatiramer acetate
Glyceryl trinitrate; for injection; for transdermal use; except in medicines containing 100 micrograms or less per litre or per kilogram
Guaiphenesin; except for oral use in medicines containing 2% or less or 200 milligrams or less
Haemophilus influenzae vaccine; except in oral vaccines for the prophylaxis of bacterial complications of colds
Hexoprenaline
Homatropine
Human protein C
Hyaluronic acid; in injections or implantations for tissue augmentation or cosmetic use
Hydrargaphen
Hydroquinone; except in medicines for external use containing 2% or less
Hylan polymer; in injections or implantations for tissue augmentation or cosmetic use
Hyoscine; except when specified elsewhere in the Schedule; except in medicines containing 300 micrograms or less per litre or per kilogram
Hyoscine butylbromide; except when specified elsewhere in the Schedule

189

Hyoscyamine; except when specified elsewhere in the Schedule; except in medicines containing 300 micrograms or less per litre or per kilogram
Hyoscyamus niger; except when specified elsewhere in the Schedule; except in medicines containing 300 micrograms or less of total solanaceous alkaloids per litre or per kilogram
Hypromellose; for injection except in intraocular viscoelastic products
Ibritumomab tiuxetan
Insulins
Isosorbide dinitrate
Juniperus sabina; at all strengths
Ketotifen; except for ophthalmic use in medicines containing 0.025% or less
Laronidase-rch
Levetiracetam
Levosimendan
Lignocaine; for oral use except in throat lozenges containing 30 milligrams or less per dose form; for ophthalmic use except when used in practice by a registered optometrist; for injection except when used as a local anaesthetic in practice by a registered nurse or podiatrist or by a dental therapist; for external use in medicines containing more than 10%
Lumiracoxib
Mebhydrolin
Meclozine; except when specified elsewhere in the Schedule
Melagatran
Melia azedarach; at all strengths
Memantine
Mepyramine; except for dermal use
Mequitazine
Mercury; except when specified elsewhere in the Schedule; except in medicines containing 1 milligram or less per litre or per kilogram
Methdilazine; except for oral use
Methyl mercury; except in medicines containing 300 micrograms of methyl mercury per litre or per kilogram
Mitragyna speciosa
Mitragynine
Muraglitazar
Nesiritide
Nicoumalone
Nitrofurazone
Norelgestromin
Nux vomica; except in medicines containing 1 milligram or less per litre or per kilogram of strychnine
Orlistat; except when specified elsewhere in the Schedule
Oxedrine; in medicines containing more than 30 milligrams per recommended daily dose
Palonosetron
Pegaptanib
Pegfilgrastim
Pemetrexed
Pentaerithrityl tetranitrate
Phenazopyridine
Pheniramine; except when specified elsewhere in the Schedule
Phenyltoloxamine; except for oral use
Piridoxine; in medicines containing more than 200 milligrams per recommended daily dose